• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

The addition of liraglutide to diet and exercise leads to increased weight loss

byXu GaoandMarc Succi, MD
July 2, 2015
in Chronic Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. For overweight and obese patients, the addition of liraglutide once daily to a diet and exercise regimen resulted in increased weight loss and improved overall health.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Obesity is an epidemic currently sweeping across the nation and worldwide. It is well documented that for overweight and obese patients, weight loss reduces morbidity and mortality. However, weight loss is often difficult to achieve and, more importantly, to maintain. Numerous agents and procedures have been developed and tested to help patients achieve weight loss. Bariatric surgery remains the most effect weight loss method. Recent drug trials have focused on glucagon-like peptide-1 (GLP-1) mimetics. These agents are theorized to work like endogenous GLP-1 in stimulating insulin secretion, lowering postprandial glucagon levels, slowing gastric emptying, and reducing appetite.

This study found that when liraglutide, a GLP-1 analogue, was added to a diet and exercise regimen in obese patients, greater weight loss was achieved. In addition, patients given liraglutide also attained statistically significant improvements in glycemic control, blood pressure, and quality of life scores. One limitation of this study is its lack of inclusion of diabetic patients. As a majority of overweight patients are often also diabetic, addition studies are needed to evaluate the effect of the drug in this population. Patients in this study were followed for a total of 56 weeks. Longer term follow up would be needed to assess for maintenance of weight loss.

Click to read the study, published today in NEJM

Click to read an accompanying editorial in NEJM

RELATED REPORTS

#VisualAbstract: Liraglutide for 56 Weeks plus lifestyle interventions reduced BMI and Body Weight in Children with Obesity

#VisualAbstract: Liraglutide may improve lower limb perfusion in people with type 2 diabetes and peripheral artery disease

Glargine and liraglutide are effective glucose-lowering medications in type 2 diabetes

Relevant Reading: Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

In-Depth [randomized controlled trial]: This trial conducted at 191 sites in 27 countries randomized 3731 patients to life style intervention plus liraglutide or lifestyle intervention plus placebo. Patients in the liraglutide group received once-daily subcutaneous injections of liraglutide, starting at a dose of 0.6 mg with weekly 0.6-mg increments to 3.0 mg. Both groups were provided counseling on lifestyle modification. At the end of 56 weeks, patients in the liraglutide group lost an average of 8.0±6.7% (8.4±7.3 kg) of their body weight as compared to patients in the placebo group who had lost an average of 2.6±5.7% (2.8±6.5 kg). In addition, a greater reduction in glycated hemoglobin, fasting glucose, and fasting insulin levels were observed in the liraglutide group than in the placebo group. The liraglutide group also scored higher on the SF-36 for overall physical and mental health as well as the Impact of Weight on Quality of Life questionnaire when compared to the placebo group.

The most common side effects experienced by patients in the liraglutide group were associated with the gastrointestinal system. Gastrointestinal events were also the most common reason that patients receiving liraglutide withdrew from the trial. Additionally, more cases of cholelithiasis and cholecystitis occurred in the liraglutide group.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: liraglutide
Previous Post

Significant bleeding following percutaneous biopsy is rare

Next Post

Citrus consumption associated with malignant melanoma

RelatedReports

#VisualAbstract: Liraglutide for 56 Weeks plus lifestyle interventions reduced BMI and Body Weight in Children with Obesity
StudyGraphics

#VisualAbstract: Liraglutide for 56 Weeks plus lifestyle interventions reduced BMI and Body Weight in Children with Obesity

February 11, 2025
#VisualAbstract: Paclitaxel-coated balloon may be superior to uncoated balloon for coronary in-stent restenosis
Chronic Disease

#VisualAbstract: Liraglutide may improve lower limb perfusion in people with type 2 diabetes and peripheral artery disease

March 28, 2024
Insulin costs rose exponentially, regardless of formulation or patent
Cardiology

Glargine and liraglutide are effective glucose-lowering medications in type 2 diabetes

September 26, 2022
Type I diabetes not associated with early menopause [OVADIA study]
Cardiology

Adjunctive glucose-lower therapies do not decrease risk of microvascular complications in diabetic patients

September 23, 2022
Next Post
Citrus consumption associated with malignant melanoma

Citrus consumption associated with malignant melanoma

CT perfusion-derived angiography aids in detecting arterial occlusion in stroke

CT perfusion-derived angiography aids in detecting arterial occlusion in stroke

Increased complications associated with emergent repeat cesarean

Increased complications associated with emergent repeat cesarean

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Brain Activation Measured on Functional MRI Predicts Response to Certolizumab, a TNF Inhibitor, in Rheumatoid Arthritis
  • 2 Minute Medicine Rewind July 14, 2025
  • New obesity framework may reclassify over half of overweight individuals as people with obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.